Literature DB >> 19748616

Age- and sex-specific yield of Barrett's esophagus by endoscopy indication.

Joel H Rubenstein1, Nora Mattek, Glenn Eisen.   

Abstract

BACKGROUND: Barrett's esophagus is a precursor of esophageal adenocarcinoma, both of which are associated with GERD. Screening GERD patients for Barrett's esophagus has been suggested, but it is not known which patients should be screened and at what age.
OBJECTIVE: To determine the age-specific yield of endoscopy for Barrett's esophagus stratified by sex and indication for endoscopy.
DESIGN: Retrospective cross-sectional study.
SETTING: National Endoscopic Database of the Clinical Outcomes Research Initiative (CORI). PATIENTS: A total of 155,641 patients undergoing their first endoscopy at one of the CORI sites for clinical indications. MAIN OUTCOME MEASUREMENTS: Age-specific yield of Barrett's esophagus.
RESULTS: Among white men with GERD, the yield of Barrett's esophagus increases steeply from early adulthood (2.1% in the third decade of life) to middle adulthood (9.3% in the sixth decade) and then plateaus (the difference for the eighth decade minus the sixth decade is -1.1%; 95% CI, -3.9% to 1.7%). There is no difference in the yield of Barrett's esophagus between middle-aged white women with GERD and white men without GERD (difference is -0.46%; 95% CI, -1.23% to 0.31%). LIMITATIONS: Possible bias by selection for endoscopy and the potential for misclassification of GERD status.
CONCLUSIONS: The yield of upper endoscopy for the diagnosis of Barrett's esophagus increases rapidly among white men with GERD until approximately age 50 and then reaches a plateau. White women with GERD are at no increased risk compared with white men without GERD. 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19748616      PMCID: PMC2813379          DOI: 10.1016/j.gie.2009.06.035

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  29 in total

1.  Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?

Authors:  A Soni; R E Sampliner; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

Review 2.  A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.

Authors:  Prateek Sharma; Kenneth McQuaid; John Dent; M Brian Fennerty; Richard Sampliner; Stuart Spechler; Alan Cameron; Douglas Corley; Gary Falk; John Goldblum; John Hunter; Janusz Jankowski; Lars Lundell; Brian Reid; Nicholas J Shaheen; Amnon Sonnenberg; Kenneth Wang; Wilfred Weinstein
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

3.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study.

Authors:  Douglas A Corley; Theodore R Levin; Laurel A Habel; Noel S Weiss; Patricia A Buffler
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

4.  Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA.

Authors:  H B El-Serag; A C Mason; N Petersen; C R Key
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

5.  Cost-effectiveness of screening a population with chronic gastroesophageal reflux.

Authors:  Paul J Nietert; Marc D Silverstein; Mahesh S Mokhashi; Christopher Y Kim; Tammy F Glenn; Vicki A Marsi; Robert H Hawes; Michael B Wallace
Journal:  Gastrointest Endosc       Date:  2003-03       Impact factor: 9.427

6.  Prevalence of Barrett's esophagus in asymptomatic individuals.

Authors:  Lauren B Gerson; Katerina Shetler; George Triadafilopoulos
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

7.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.

Authors:  Douglas K Rex; Oscar W Cummings; Michael Shaw; Mark D Cumings; Roy K H Wong; Raj S Vasudeva; Donal Dunne; Emad Y Rahmani; Debra J Helper
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.

Authors:  John M Inadomi; Richard Sampliner; Jesper Lagergren; David Lieberman; A Mark Fendrick; Nimish Vakil
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

9.  Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia.

Authors:  Gregory S Cooper; Zhong Yuan; Amitabh Chak; Alfred A Rimm
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

10.  Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006.

Authors:  D A Corley; A Kubo; T R Levin; G Block; L Habel; G Rumore; C Quesenberry; P Buffler
Journal:  Gut       Date:  2008-10-31       Impact factor: 23.059

View more
  28 in total

Review 1.  Barrett's esophagus: diagnosis and management.

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2017-01-18       Impact factor: 9.427

2.  Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video).

Authors:  Anne F Peery; Toshitaka Hoppo; Katherine S Garman; Evan S Dellon; Norma Daugherty; Susan Bream; Alejandro F Sanz; Jon Davison; Melissa Spacek; Diane Connors; Ashley L Faulx; Amitabh Chak; James D Luketich; Nicholas J Shaheen; Blair A Jobe
Journal:  Gastrointest Endosc       Date:  2012-03-16       Impact factor: 9.427

Review 3.  Ambulatory reflux monitoring in GERD--which test should be performed and should therapy be stopped?

Authors:  Andrew J Gawron; John E Pandolfino
Journal:  Curr Gastroenterol Rep       Date:  2013-04

4.  Low Prevalence of Suspected Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease Without Alarm Symptoms.

Authors:  Emery C Lin; Jennifer Holub; David Lieberman; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-07       Impact factor: 11.382

5.  Regional Variability of Repeat Esophagogastroduodenoscopy Use in the National Veteran Population.

Authors:  Andrew J Gawron; Garrett Cole; Nan Hu; William K Thompson; John Fang; Matthew Samore
Journal:  Dig Dis Sci       Date:  2017-07-31       Impact factor: 3.199

Review 6.  Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.

Authors:  Takeshi Kanno; Paul Moayyedi
Journal:  Curr Gastroenterol Rep       Date:  2019-12-05

7.  The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders.

Authors:  Muhammad Ali Khan; Colin W Howden
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

8.  MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.

Authors:  Katherine S Garman; Kouros Owzar; Elizabeth R Hauser; Kristen Westfall; Blair R Anderson; Rhonda F Souza; Anna Mae Diehl; Dawn Provenzale; Nicholas J Shaheen
Journal:  Dig Dis Sci       Date:  2013-08-08       Impact factor: 3.199

9.  Prediction of Barrett's esophagus among men.

Authors:  Joel H Rubenstein; Hal Morgenstern; Henry Appelman; James Scheiman; Philip Schoenfeld; Laurence F McMahon; Valbona Metko; Ellen Near; Joan Kellenberg; Tal Kalish; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2013-01-15       Impact factor: 10.864

Review 10.  Review on novel concepts of columnar lined esophagus.

Authors:  Johannes Lenglinger; Stephanie Fischer See; Lukas Beller; Enrico P Cosentini; Reza Asari; Fritz Wrba; Martin Riegler; Sebastian F Schoppmann
Journal:  Wien Klin Wochenschr       Date:  2013-09-06       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.